Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:14:49 UTC |
---|
HMDB ID | HMDB0000428 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 3-Hydroxyglutaric acid |
---|
Description | 3-Hydroxyglutaric acid is a member of the class of compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. 3-Hydroxyglutaric acid is soluble (in water) and a weakly acidic compound (based on its pKa). When present in sufficiently high levels, 3-hydroxyglutaric acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of 3-hydroxyglutaric acid are associated with glutaric aciduria type I (glutaric acidemia type I, glutaryl-CoA dehydrogenase deficiency, GA1, or GAT1). GA1 is an inherited disorder in which the body is unable to completely break down the amino acids lysine, hydroxylysine, and tryptophan due to a deficiency of mitochondrial glutaryl-CoA dehydrogenase (EC 1.3.99.7, GCDH). Excessive levels of their intermediate breakdown products (e.g. glutaric acid, glutaryl-CoA, 3-hydroxyglutaric acid, glutaconic acid) can accumulate and cause damage to the brain (and also other organs), but particularly the basal ganglia. GA1 is associated with a risk for intracranial and retinal hemorrhage, and non-specific white matter changes. Babies with glutaric acidemia type I are often born with unusually large heads (macrocephaly). Other symptoms include spasticity (increased muscle tone/stiffness) and dystonia (involuntary muscle contractions resulting in abnormal movement or posture), but many affected individuals are asymptomatic. Seizures and coma (encephalopathy) are rare. GA1 also causes secondary carnitine deficiency because 3-hydroxyglutaric acid, like other organic acids, is detoxified by carnitine. |
---|
Structure | InChI=1S/C5H8O5/c6-3(1-4(7)8)2-5(9)10/h3,6H,1-2H2,(H,7,8)(H,9,10) |
---|
Synonyms | Value | Source |
---|
3-Hydroxy-glutaric acid | ChEBI | beta-Hydroxyglutaric acid | ChEBI | 3-Hydroxy-glutarate | Generator | b-Hydroxyglutarate | Generator | b-Hydroxyglutaric acid | Generator | beta-Hydroxyglutarate | Generator | Β-hydroxyglutarate | Generator | Β-hydroxyglutaric acid | Generator | 3-Hydroxyglutarate | Generator | 3-Hydroxypentanedioic acid | HMDB | 2,4-Dideoxypentaric acid | HMDB | 3-Hydroxypentanedioate | HMDB | 3-Hydroxyglutaric acid | MeSH |
|
---|
Chemical Formula | C5H8O5 |
---|
Average Molecular Weight | 148.114 |
---|
Monoisotopic Molecular Weight | 148.037173366 |
---|
IUPAC Name | 3-hydroxypentanedioic acid |
---|
Traditional Name | 3-hydroxyglutaric acid |
---|
CAS Registry Number | 638-18-6 |
---|
SMILES | OC(CC(O)=O)CC(O)=O |
---|
InChI Identifier | InChI=1S/C5H8O5/c6-3(1-4(7)8)2-5(9)10/h3,6H,1-2H2,(H,7,8)(H,9,10) |
---|
InChI Key | ZQHYXNSQOIDNTL-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Hydroxy acids and derivatives |
---|
Sub Class | Beta hydroxy acids and derivatives |
---|
Direct Parent | Beta hydroxy acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Short-chain hydroxy acid
- Beta-hydroxy acid
- Fatty acid
- Dicarboxylic acid or derivatives
- Secondary alcohol
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
3-Hydroxyglutaric acid,1TMS,isomer #1 | C[Si](C)(C)OC(CC(=O)O)CC(=O)O | 1429.7 | Semi standard non polar | 33892256 | 3-Hydroxyglutaric acid,1TMS,isomer #2 | C[Si](C)(C)OC(=O)CC(O)CC(=O)O | 1437.2 | Semi standard non polar | 33892256 | 3-Hydroxyglutaric acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CC(CC(=O)O)O[Si](C)(C)C | 1502.1 | Semi standard non polar | 33892256 | 3-Hydroxyglutaric acid,2TMS,isomer #2 | C[Si](C)(C)OC(=O)CC(O)CC(=O)O[Si](C)(C)C | 1524.4 | Semi standard non polar | 33892256 | 3-Hydroxyglutaric acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CC(CC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 1586.4 | Semi standard non polar | 33892256 | 3-Hydroxyglutaric acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(CC(=O)O)CC(=O)O | 1676.5 | Semi standard non polar | 33892256 | 3-Hydroxyglutaric acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CC(O)CC(=O)O | 1717.9 | Semi standard non polar | 33892256 | 3-Hydroxyglutaric acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC(CC(=O)O)O[Si](C)(C)C(C)(C)C | 1978.4 | Semi standard non polar | 33892256 | 3-Hydroxyglutaric acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CC(O)CC(=O)O[Si](C)(C)C(C)(C)C | 1976.8 | Semi standard non polar | 33892256 | 3-Hydroxyglutaric acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC(CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2213.7 | Semi standard non polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0536-9200000000-95922095d2aa1db75f8b | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (3 TMS) - 70eV, Positive | splash10-00gs-9081000000-c273d86d7f22986f4bcd | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyglutaric acid GC-MS (TBDMS_3_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 40V, Negative-QTOF | splash10-0a4l-9000000000-9249b84ab50ffbbbab00 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 20V, Negative-QTOF | splash10-0a4i-9100000000-a007a5c975eeaa894298 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 10V, Negative-QTOF | splash10-0fbi-4900000000-111cef5b8a6a577bf701 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 10V, Positive-QTOF | splash10-01qa-1900000000-83e00bd7b92b7f2f9832 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 20V, Positive-QTOF | splash10-01qi-5900000000-da4f8a92eae4f7ae9a73 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 40V, Positive-QTOF | splash10-000i-9000000000-a255aedbfaa3bce837b8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 10V, Negative-QTOF | splash10-0002-2900000000-6ea9c60bf78cda297a39 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 20V, Negative-QTOF | splash10-0pbj-9800000000-db9f014d4e5dce1cc78f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 40V, Negative-QTOF | splash10-0a4i-9100000000-89edd1cbe710cf97835d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 10V, Positive-QTOF | splash10-0019-9400000000-3231e946df512b24401a | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 20V, Positive-QTOF | splash10-0076-9200000000-4ffdd7ac7861294da783 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 40V, Positive-QTOF | splash10-006x-9000000000-f46770ad7298e670b4b7 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 10V, Negative-QTOF | splash10-0f72-5900000000-c4e9005c7c37f89f6fe3 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 20V, Negative-QTOF | splash10-052f-9100000000-de505ca4195705703e19 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyglutaric acid 40V, Negative-QTOF | splash10-0a4l-9000000000-cae7897ab9482c2d43bc | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 500 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.15 +/- 0.08 uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | <0.2 uM | Not Specified | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.07 +/- 0.03 uM | Not Specified | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 22-67 uM | Not Specified | Not Specified | Normal | | details | Urine | Detected and Quantified | 41-44 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 0-3 umol/mmol creatinine | Newborn (0-30 days old) | Male | Normal | | details | Urine | Detected and Quantified | <11.51 umol/mmol creatinine | Children (1 - 18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 1.8 uM | Newborn (0-30 days old) | Male | Glutaric aciduria I | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 4450 uM | Not Available | Not Specified | Glutaryl-CoA dehydrogenase deficiency (GDHD) | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 4450 uM | Children (1-13 years old) | Not Specified | Glutaric acid excretion above 100 mmol/mol creatinine | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 2.2 uM | Newborn (0-30 days old) | Male | Glutaric aciduria I | | details | Urine | Detected and Quantified | 3.68 umol/mmol creatinine | Adolescent (13-18 years old) | Female | Glutaric aciduria I | | details | Urine | Detected and Quantified | 590 umol/mmol creatinine | Newborn (0-30 days old) | Male | Glutaric aciduria I | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Bladder cancer | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Glutaric aciduria I |
---|
- Poge AP, Autschbach F, Korall H, Trefz FK, Mayatepek E: Early clinical manifestation of glutaric aciduria type I and nephrotic syndrome during the first months of life. Acta Paediatr. 1997 Oct;86(10):1144-7. [PubMed:9350903 ]
- Fraidakis MJ, Liadinioti C, Stefanis L, Dinopoulos A, Pons R, Papathanassiou M, Garcia-Villoria J, Ribes A: Rare Late-Onset Presentation of Glutaric Aciduria Type I in a 16-Year-Old Woman with a Novel GCDH Mutation. JIMD Rep. 2015;18:85-92. doi: 10.1007/8904_2014_353. Epub 2014 Sep 26. [PubMed:25256449 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Glutaryl-CoA dehydrogenase deficiency (GDHD) |
---|
- Baric I, Wagner L, Feyh P, Liesert M, Buckel W, Hoffmann GF: Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis. 1999 Dec;22(8):867-81. [PubMed:10604139 ]
|
|
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB04594 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022040 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 158277 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Alpha-Hydroxyglutaric acid |
---|
METLIN ID | 5417 |
---|
PubChem Compound | 181976 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 39980 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | MDB00000160 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Arnaud, Nathalie; Picard, Claude; Cazaux, Louis; Tisnes, Pierre. Synthesis of macrocyclic polyhydroxy tetralactams derived from L-tartaric acid and b-hydroxyglutaric acid. Tetrahedron (1997), 53(40), 13757-13768. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Baric I, Wagner L, Feyh P, Liesert M, Buckel W, Hoffmann GF: Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis. 1999 Dec;22(8):867-81. [PubMed:10604139 ]
- Kolker S, Hoffmann GF, Schor DS, Feyh P, Wagner L, Jeffrey I, Pourfarzam M, Okun JG, Zschocke J, Baric I, Bain MD, Jakobs C, Chalmers RA: Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. Neuropediatrics. 2003 Jun;34(5):253-60. [PubMed:14598231 ]
- Wajner M, Kolker S, Souza DO, Hoffmann GF, de Mello CF: Modulation of glutamatergic and GABAergic neurotransmission in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2004;27(6):825-8. [PubMed:15505388 ]
- Nyhan WL, Zschocke J, Hoffmann G, Stein DE, Bao L, Goodman S: Glutaryl-CoA dehydrogenase deficiency presenting as 3-hydroxyglutaric aciduria. Mol Genet Metab. 1999 Mar;66(3):199-204. [PubMed:10066389 ]
- Molven A, Matre GE, Duran M, Wanders RJ, Rishaug U, Njolstad PR, Jellum E, Sovik O: Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes. 2004 Jan;53(1):221-7. [PubMed:14693719 ]
- Haworth JC, Booth FA, Chudley AE, deGroot GW, Dilling LA, Goodman SI, Greenberg CR, Mallory CJ, McClarty BM, Seshia SS, et al.: Phenotypic variability in glutaric aciduria type I: Report of fourteen cases in five Canadian Indian kindreds. J Pediatr. 1991 Jan;118(1):52-8. [PubMed:1986098 ]
- Sauer SW, Okun JG, Fricker G, Mahringer A, Muller I, Crnic LR, Muhlhausen C, Hoffmann GF, Horster F, Goodman SI, Harding CO, Koeller DM, Kolker S: Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem. 2006 May;97(3):899-910. Epub 2006 Mar 29. [PubMed:16573641 ]
|
---|